Bulletin
Investor Alert

Topics

Options Trading

Video

How Robinhood Is Shaking Up the Brokerage Industry

  • How Robinhood Is Shaking Up the Brokerage Industry How Robinhood Is Shaking Up the Brokerage Industry 8:15
    A Red Flag for the Greenback? A Red Flag for the Greenback? 0:29
    Your ultimate guide to trading terms | How to Invest: Ep. 7 Your ultimate guide to trading terms | How to Invest: Ep. 7 2:34
    How Options-Trading Redditors Fed the GameStop Frenzy How Options-Trading Redditors Fed the GameStop Frenzy 4:14
9:58 a.m. Today - By Emily Bary
Bumble stock rockets after company lands a new 'BFF'Shares of Bumble Inc. have declined 28% over the past month, but one analyst thinks that investors are misunderstanding the company's story.
3:30 a.m. Today - By Mark DeCambre
Gold futures edge up, even as dollar, yields inch higherGold futures were rising slightly on Tuesday, with a rally in global stocks, a rise in Treasury yields and a firming dollar likely capping the move for the precious commodity.
11:59 p.m. Dec. 5, 2021 - MarketWatch.com
9 financial gift ideas for kids and grandkidsNo worries about supply-chain disruptions or late deliveries with these gifts. Here are some great ways to help kids learn more about money.
7:30 p.m. Dec. 5, 2021 - Barrons.com
The Housing Boom Could Last for a Decade. Buy These Stocks. Publicly traded home builders have a bigger share of the market and stronger balance sheets than they did in the last big boom. Plus, their stocks trade cheaply.
12:47 p.m. Dec. 4, 2021 - By Brett Arends
Should you put your 401(k) in a '3X' retirement portfolio?So much for the wisdom of the experts
9:51 a.m. Dec. 4, 2021 - By Lawrence G. McMillan
These stock-market signals will tell you when it's safe to buy againThe S&P 500's plunge exposed weak internal factors.
3:21 a.m. Dec. 4, 2021 - By Michael Sincere
In his final warning, this stock trading wizard --- who made big money in bear markets and crashes --- called this market a bubble like no otherVeteran trader Mark D. Cook, who passed away recently, closely monitored the market's health and was convinced that U.S. stocks are due for a major hit.
10:20 a.m. Dec. 3, 2021 - By Mark Decambre
Wall Street's 'fear index' shoots to highest level since January as S&P 500 skids lower, Nasdaq sinks toward correction A measure of implied volatility on Wall Street on Friday touched the highest level since late January as the S&P 500 index headed toward its second consecutive weekly loss. The CBOE Volatility Index jumped by about 24% Friday, trading around 34.6, which would mark the highest level for the index since Jan. 27, according to FactSet data. The index, also known as the VIX, for its ticker symbol, has become well known as Wall Street's "fear index," since it was created in the early 1990s. The VIX itself, which uses S&P 500 options to measure trader expectations for volatility over the coming 30-day period, tends to rise as stocks fall and is often therefore referred to as a guide to the level of investor fear. It had been trading below its historic average of around 19.5 until concerns about the omicron variant of the coronavirus that causes COVID-19 emerged last week. This Friday, the VIX was headed higher in the culimination of a weeklong selloff in equities as investors reassessed a weaker-than-expected November jobs report as unlikely to stay the hand of a Federal Reserve that seems intent on tamping down inflation. Meanwhile, the Nasdaq Composite Index , off 2.7%, was seeing the most significant selling pressure, among the main three stock benchmarks, bringing the index down more than 6% from its Nov. 19 record peak.
10:03 a.m. Dec. 3, 2021 - By Tomi Kilgore
Eli Lilly's COVID-19 treatment now authorized high-risk patients 'of any age'Eli Lilly & Co. said Friday that the U.S. Food and Drug Administration has expanded the Emergency Use Authorization (EUA) for its bamlanivimab and etesevimab, taken together, to treat certain high-risk patients that are under the age of 12, even newborns. "With the FDA's decision to allow use of bamlanivimab with etesevimab in children and infants, Lilly can now offer treatment and prevention options to high-risk individuals of any age," said Daniel Skovronsky, Lilly's chief scientific and medical officer. Lilly said bamlanivimab and etesevimab taken together retains neutralization activity against the delta variant of the coronavirus that causes COVID-19, and the drug maker is working to understand neutralization activity on the omicron variant. Lilly's stock, which fell 1.9% in afternoon trading Friday, has rallied 44.0% year to date, while the S&P 500 has gained 19.7%.
9:28 a.m. Dec. 3, 2021 - By Tomi Kilgore
Merck to supply Government of Canada with up to 1 million courses molnupiravir, its COVID-19 pillMerck & Co. Inc. said Friday that it has entered into an agreement to supply the Government of Canada with up to one million patient courses of its COVID-19 pill, molnupiravir, which is being developed in collaboration with Ridgeback Biotherapeutics. Earlier this week, an that the drug maker's oral antiviral treatment of COVID-19 be authorized by the U.S. Food and Drug Administration. Under terms of the supply agreement, Merck will supply 500,000 patient courses of molnupiravir in 2022, and has granted options for up to 500,000 more courses, pending approval by Health Canada. Merck's stock fell 0.8% in afternoon trading. It has lost 5.1% over the past three months, while the Dow Jones Industrial Average , of which Merck is a component, has slipped 2.7%.
5:51 a.m. Dec. 3, 2021 - By Andrew Keshner
Google just paused January 2022 office return plans amid omicron — will other companies follow?Before the omicron variant emerged, data indicated more people were physically back in the office and fewer were working at home.
2:29 a.m. Dec. 3, 2021 - Barrons.com
Elon Musk's Tesla Stock Sales Resume. But He Can't Avoid California Tax. Tesla CEO Elon Musk sold more Tesla stock. The sales were part of his prearranged plan to exercise expiring management stock options.
3:41 a.m. Dec. 1, 2021 - By Emily Bary
Match settles lawsuit with former Tinder employees for $441 millionMatch Group Inc. disclosed Wednesday that it has settled a lawsuit with former Tinder employees led by Tinder cofounder Sean Rad.
10:11 a.m. Nov. 30, 2021 - Barrons.com
Never Mind Elon Musk's Stock Sales. Look What Microsoft's CEO Just Did. CEO Satya Nadella sold about half his stake in the software company, according to recent filings with the Securities and Exchange Commission.
5:37 a.m. Nov. 29, 2021 - Barrons.com
Li Auto Sales Surge More Than 200% Chinese electric vehicle maker Li Auto reports $1.21 billion in third-quarter sales. Wall Street was looking for $1.13 billion.
4:47 a.m. Nov. 27, 2021 - By Thornton McEnery
On a very Black Friday for investors, many Reddit Apes were talking about buying and HODLingWall Street's worst day of 2021 was viewed a little differently in some corners of social media.
2:42 a.m. Nov. 26, 2021 - By Mark Decambre
Wall Street's 'fear index' surges by most in 10 months as Dow and S&P 500 set to tumble on COVID variant worriesA measure of implied volatility on Wall Street on Black Friday touched the highest level since around September as futures for the Dow Jones Industrial Average [: DJIA] and the S&P 500 index , looked set to tumble amid concerns of a fast-spreading strain of coronavirus, which was identified in South Africa, Hong Kong and Israel and was already leading to travel restrictions. The CBOE Volatility Index jumped by about 40% Friday morning, trading around 25.4, which would mark the highest level for the index since around Sept. 20 and mark the biggest daily jump for the measure since late January, according to FactSet data. The index, also known as the VIX, for its ticker symbol, has become well known as Wall Street's "fear gauge," since it was created in the early 1990s. The VIX itself, which uses S&P 500 options to measure trader expectations for volatility over the coming 30-day period, tends to rise as stocks fall and is often therefore referred to as a guide to the level of investor fear. It had been trading below its historic average of around 19.5.
8:16 a.m. Nov. 24, 2021 - By Lawrence G. McMillan
The stock market has had trouble holding new highs, but it's entering a bullish periodPlus: A new seasonal buy signal for small-cap stocks.
4:09 a.m. Nov. 24, 2021 - By Tomi Kilgore
Charter Communications CEO Rutledge sells stock, raising more than $59 millionCharter Communications Inc. disclosed Wednesday that Chairman and Chief Executive Thomas Rutledge sold 88,000 of the broadband communications services company's shares in the open market over the past two days, to raise about $59.4 million. The weighted average price of the stock sales was at $674.82, according to a MarketWatch analysis, or just above Tuesday's closing price of $674.74. The Form 4 filed with the Securities and Exchange Commission showed that Rutledge sold 43,106 at an average price of $674.3398 on Nov. 22 and sold 44,894 shares at $675.2855 on Nov. 23. The shares sold represented about 26.5% of his Rutledge's stake in the company, according to FactSet data, but Charter said that does not include options to buy company stock that are beneficially owned by Rutledge. The stock, which slipped 0.1% in premarket trading, has dropped 14.9% over the past three months through Tuesday, while the SPDR Communication Services Select Sector ETF has lost 6.5% and the S&P 500 has gained 4.6%.
3:47 a.m. Nov. 24, 2021 - By Barbara Kollmeyer
A bear market awaits tech stocks, with Tesla at the center, if this selloff continues, strategist warnsOur call of the day is looking at what happened with bond yields earlier this year and raising a red flag over tech stocks.
3:58 p.m. Nov. 23, 2021 - By Tomi Kilgore
These are the most important things to check on a stock's quote page before deciding whether to buy or sellThere's a lot more to glean from a MarketWatch stock quote page than just the price and the change from the previous session. In fact, price may be one of the least useful pieces of information.
1:02 p.m. Nov. 23, 2021 - By Thornton McEnery
Some squeeze-loving retail investors are being cautious about all those shorts on LongeveronThe biopharma stock shot up more than 865% in 3 days before massive short interest dragged it down almost 50% on Tuesday, but will the Apes pounce?
3:11 a.m. Nov. 23, 2021 - Barrons.com
This Anti-ARK ETF Has Gained 10% in Two Weeks The Tuttle Capital Short Innovation ETF, launched in early November, tracks the inverse performance of the ARK Innovation ETF. The former has surged as the latter has struggled.
3:00 a.m. Nov. 23, 2021 - Barrons.com
Wealth Managers Trail Other Finance Companies in Mobile App Customer Satisfaction Investing apps trail insurance and credit card apps in new ratings from J.D. Power. But U.S. Bancorp and Chase Mobile were tops in the category.
2:52 a.m. Nov. 22, 2021 - Barrons.com
A Tesla Executive Sold Stock. It Wasn't Elon Musk. Tesla investors check in daily, tracking CEO Elon Musk's stock sales.
11:15 p.m. Nov. 21, 2021 - Barrons.com
Stock Options Are the New Day-Trading Craze. What It Means for the Market. Equity option volumes are nearing the levels reached during the meme-stock frenzy in January. Investors need to be aware of the risks.
11:12 a.m. Nov. 20, 2021 - By Lawrence G. McMillan
Stock-market bears have a narrow window to capitalize on any S&P 500 sell signalsThe S&P 500 chart is still positive, but some confirmed sell signals are appearing.
4:57 a.m. Nov. 20, 2021 - MarketWatch.com
Want to jump into crypto investing? Ask yourself these 3 questions first The approach to investing in cryptocurrency isn’t so different from other investments that have a high-risk profile. Here's what to consider.
3:36 p.m. Nov. 19, 2021 - Barrons.com
As Musk Sells, Uber CEO Buys $9 Million in Shares Uber CEO Dara Khosrowshahi’s purchase helped push Uber stock higher on Tuesday. The gains were fleeting. Tesla CEO Elon Musk disclosed stock sales in response to a Twitter poll in which users voted for him to sell 10% of his stake. Tesla stock mostly held up.
6:27 a.m. Nov. 19, 2021 - Barrons.com
'Big Short' Investor Has an 'Absolute, No-Brainer' Idea to Fix Car Stocks' Crazy Valuations Michael Burry says Ford and GM should issue tracking stocks for their EV operations to close the valuation gap with companies like Tesla and Rivian.
11:13 a.m. Nov. 18, 2021 - By Myra P. Saefong
Oil rebounds after reports of a U.S. push for coordinated release of crude reserves send prices to 6-week lowsOil finishes higher on Thursday, with prices rebounding after dropping to their lowest levels in about six weeks on reports that China plans a release of crude from its reserve and news that the Biden administration has been pressing other countries to join in.
10:59 a.m. Nov. 18, 2021 - By Christine Idzelis
Should stock-market investors who ‘missed the rally’ buy now? Here’s what UBS saysInvestors who are worried about having “missed the rally” in equities may still reap profits from buying now and seeking exposure to areas like midcap stocks in the U.S., according to UBS Group’s global wealth-management division.
2:38 a.m. Nov. 18, 2021 - By Ciara Linnane
Arcus Biosciences shares rocket premarket after Gilead exercises options for 3 cancer programs for $725 millionShares of Arcus Biosciences Inc. rocketed 21% in premarket trading Thursday, after Gilead Sciences Inc. said it's exercising options to three programs in the company's clinical-stage portfolio for payments of $725 million. The programs in question include anti-TIGIT molecules, domvanalimab and AB308, as well as etrumadenant and quemliclustat, treatments for different cancers. The companies have also agreed to a research collaboration that will allow them to add Gilead portfolio candidates to existing Arcus studies. "The addition of three mid- to late-stage clinical programs into our oncology pipeline significantly expands the number of transformational medicines we can potentially deliver to people with cancer, while also enabling our pursuit of novel combinations," Gilead CEO Daniel O'Day said in a statement. Arcus shares have gained 42% in the year to date, while the SPDR S&P Biotech ETF has fallen 12.7% and the S&P 500 has gained 25%.
12:36 a.m. Nov. 18, 2021 - Barrons.com
Sweetgreen Raises $364 Million in IPO That Prices Above Marketed Range Sweetgreen's IPO is priced at $28 a share, higher than the marketed range of $23 to $25.
9:12 a.m. Nov. 17, 2021 - By Chris Matthews
'One of the stupidest ideas I've heard in a long time,' Robinhood CLO blasts Coinbase crypto regulator proposalThe digital assets industry remains laser focused on the looming threat of regulation, but players in the space are not of one mind on the question of how the federal government should regulate the market for cryptocurrencies.
5:28 a.m. Nov. 17, 2021 - By Emily Bary
Apple makes a concession to 'right to repair' movement, will let you repair your own iPhoneApple Inc. will start allowing customers to repair their own devices with genuine parts, the consumer-electronics giant said Wednesday.
5:27 a.m. Nov. 17, 2021 - By Barbara Kollmeyer
Visa is ‘very disappointed’ Amazon will stop accepting its U.K. credit cardsAfter the holidays, Amazon shoppers in the U.K. will have to find an alternative for their Visa credit cards, after the e-commerce giant announced new rules.
5:26 a.m. Nov. 17, 2021 - Barrons.com
Braze Raises $520 Million as IPO Prices Above Expected Range The initial public offering for Braze, the maker of customer engagement software, is priced at $65 a share.
3:49 a.m. Nov. 17, 2021 - Barrons.com
The Big Winner From Elon Musk's Stock Options Pay Package? The Government, of Course. Another day, another batch of stock sales—and more tweets about taxation—from Tesla CEO Elon Musk.
6:07 a.m. Nov. 16, 2021 - Barrons.com
Tesla Stock Gets a Lift as 'Big Short' Investor Michael Burry Exits Bet The latest quarterly filing from Scion Asset Management, Michael Burry's firm, shows no bearish bets against the electric-vehicle company.
Browse topics:

Filter results by

Location

Us (73)

Asia Pacific (2)

Canada (2)

Eu (1)

Europe (1)

Link to MarketWatch's Slice.